A ghrelin-mimetic appetite stimulant approved for companion animals.
Also known as: Entyce · Elura · CP-424391
Part of the Growth hormone & IGF peptides cluster
Overview
Capromorelin is an orally active ghrelin/growth hormone secretagogue receptor agonist that increases appetite and stimulates growth hormone release. It is FDA-approved for veterinary use as an appetite stimulant in dogs and cats; human development was discontinued. This page is educational and is not medical advice.
Source & context
Biological / chemical source: Synthetic orally active peptidomimetic
Primary research or clinical context: FDA-approved for veterinary use as an appetite stimulant in dogs and cats; human development was discontinued
Veterinary appetite stimulant
Marketed as Entyce and Elura, capromorelin is used to address inappetence and weight loss in companion animals. Its ghrelin-receptor activity drives both appetite signaling and downstream growth hormone and IGF-1 effects.
From human trials to animal health
Capromorelin was originally studied in humans, including trials in older adults, before human development was halted. Its path into veterinary medicine is a common story for ghrelin-mimetic secretagogues.
FAQ about Capromorelin
What is Capromorelin?+
Capromorelin is an orally active ghrelin/growth hormone secretagogue receptor agonist that increases appetite and stimulates growth hormone release. It is FDA-approved for veterinary use as an appetite stimulant in dogs and cats; human development was discontinued. This page is educational and is not medical advice.
Is Capromorelin an approved medicine?+
Capromorelin: FDA-approved for veterinary use as an appetite stimulant in dogs and cats; human development was discontinued. Always follow licensed medical guidance for approved products.
What is the typical length of Capromorelin?+
Capromorelin is not a classic amino-acid chain peptide in the same sense; see the profile for classification details.